Bivarus is a healthcare IT company that has developed an elegant and efficient patient survey platform. Acquired by Press Ganey Associates in January 2018.

(BITT) is a Boston-based biopharmaceutical company developing immune-based approaches for the treatment of cancer and infectious diseases.

Developer of a technology designed to extract highly sensitive nucleic acid quantification. Acquired by Bio-Rad 2021

Provider of a clinical research platform intended to revolutionize the clinical research industry

Kymera is developing a heterobifunctional small molecule drug platform. IPO in August 2020 (NASDAQ: KYMR).

Provider of patient experience platform designed to facilitate the relationship between physicians and patients. Acquired by NextGen 2019

Developer of staffing, communication and schedule management tools designed to modernize staffing processes. Acquired by HealthStream 2020

Perfuse Therapeutics, Inc. is a seed stage biotechnology company focusing on improving retinal perfusion

Developer of a molecular diagnostics technology designed to dramatically reduce time to results in microbiology.

A developer of multiple antibiotic drugs intended to combat antimicrobial resistance. Acquired by Shionogi 2023

The SHAPE-MaP technology developed in the lab of Dr. Weeks identifies functional motifs within RNA by mapping the RNA three-dimensional structure.

Developer of epigenetic drugs intended to be used for the treatment of cognitive disorders and diseases of the brain. Acquired by NASDAQ: ALKS in Nov 2019

Standard Bariatrics is developing a clamp and stapler to standardize sleeve gastrectomy procedures. Acquired by Teleflex in September 2022.

Stridebio is developing engineered viral vectors for gene therapy. Acquired by Ginkgo Bioworks 2023

Developer of novel engineered compounds designed to corneal dystrophies, improve human health and create new therapies using drugs developed with protein engineering.
